untitled - PDF 免费下载

理 CNIC9503 3 行 95 年 1 1 95 年 12 31 林 96 年 02 27

料來理 (1) (2) (3) 率立了率不不率 DPPH 力 TEAC OH 率老行 2 年 7% 度 GDP 率兩來 (1) 力類來 (2) 力量行略 (3) 理行 - 1 -

來老行老年領類利類老流行金都都類降罹率不了率 - 2 -

留率不年了利不 A. 1 DPPH 力 DPPH 藍力 DPPH 來力若 DPPH DPPH 行連 DPPH 力 DPPH 力不度利度 (ELISA reader) OD 540 nm - 3 -

IC 50 力 DPPH 力 ( ) = [1- A540 nm, sample/a540nm, blank)] 100 2 TEAC 力 ABTS ABTS. + 離藍綠若 ABTS. + 離力降力 trolox TEAC 力力力不度利度 OD 734 nm IC 50 力力 ( ) = [1-(A734 nm, sample / A734 nm, blank)] 100-4 -

3 冷力 I II III IV (a) (b) (c) (d) (e) (f) (g) 50µL I 量 1 ml II 量 1.6 ml III 量 100µL IV 量量數量冷冷數 10µL 冷 (h) 冷量冷度降數 - 5 -

冷 ( A A intial - A sample ) 冷 (A intial ) 論 DPPH system TEAC system 力 DPPH system 度 0.088 µg/ml CF GR RR 率 85.6 % 83.9% 51.6% TEAC system 度 0.04 µg/ml GR CF TH 率 94.4 % 80.9% 76.0%( 1) DPPH system TEAC system GR CF 力 ME 力 GR CF sample sample - 6 -

離行力 Trolox EGCG Ascorbic acid 1. 力度率 DPPH system 0.088 µg/ml CF 85.6% GR 83.9% RR 51.6% TEAC system 0.04 µg/ml GR 94.4% CF 80.9% TH 76.0% 力力 2 DPPH system HGR AGR EGCG 力 ACF Trolox 力 HME AME 力 TEAC system 類來說 EGCG 力 HGR AGR EGCG 力 ACF 不論 DPPH system - 7 -

TEAC system 力 HCF 來力 Trolox 2. DPPH system TEAC system IC 50 (ppm) DPPH system TEAC system HGR 1.44 1.66 AGR 1.45 1.75 HCF 6.81 4.07 ACF 4.42 3.36 HME 16.03 6.67 AME 16.55 5.01 Trolox 4.89 4.33 EGCG 1.58 1.77 Ascorbic acid 8.67 3.89 HGR AGR OH 力 EGCG Ascorbic acid 力 HCF Trolox OH 力 HME AME OH - 力 O 2 Trolox 數參 H 2 O 2 力 HGR ACF HME 力 HCF AME 力 - 8 -

六參 1. 林奈利行料 2004, 6 2. N.-H. Shin; S. Y. Ryu; E. J. Choi; S.-H. Kang; I.-M. Chang; K. R. Min; Y. Kim. Biochem. and Biophy. Research Commun. 1998, 243, 801. 3. N. Baurin; E. Arnoult; T. Scior; Q.T. Do; P. Bernard; J. Ethnopharmacology, 2002, 82, 155. 4. J. P. Ley; H. J. Bertram; Bioorg.& Med. Chem. 2001, 9, 1897. 5. L. Startor; E. Pezzato; I. Dell; R. Caiato; Biochem. Pharm. 2002, 64, 229. 6. I. Kubo; K.-I. Nihei; K. Tsujimoto; Bioorg. & Med. Chem. 2004.12.5349. 7. I. Kubo; P. Xiao; K.-I, Fujita; Bioorg. & Med. Chem. Lett. 2001.11.347. 8. S. H. Lee; S. Y. Chio; H. Kim. J. S. Hwang; B. G. Lee; Biol. Pharm. Bull. 2002, 25, 1045. 9. S. Rudra; A. V. Eliseev; J. Am. Chem. Soc. 1998, 120, 11543. 10. I. Kubo; P. Xiao; K.-I. Nichi, K.-I. Fujita; J. Agric. Food Chem. 2002, 50, 3992. 11. S. Y. Choi; S. Kim; J. S. Hwang; B. G. Lee; H. Kim; S. Y. Kim; Biochem. Pharm. 2004, 67, 707. 12. S. Y. Chio; S. Kim. H. Kim; K. Suk; J. S. Hwang; B. G. Lee; A.-J. Kim; S. Y. Kim; Chem. Pharm. Bull. 2002, 50, 450. 13.Bernard, P. and Berthon, J. Y. 2000. Resveratrol: an original mechanism on tyrosinase inhibition. International journal of Cosmetic Science. 22, 219-226. 14.Boots the chemist Ltd. The guide to practical measurement of UVA/UVB ratios. The Boots Chemist, PLC, Nottingham, England. 15.Cabanes, J. et al. 1994. Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase. J. Pharm. Pharmacol. 46, 982-985. - 9 -

16.Easton, A. Women have deadly desire for paler skin in the Philippines. The Lancet 352, 555. 17.Fitzpartrick, T. B. 1995. Pathophysiology of hypermelanoses. Clin. Drug. Invest. 10 (suppl. 2) 18.Goihman-Yahr, M. 1996. Skin aging and photoaging: an outlook. Clinics in Dermatology. 14,153-160. 19.Lee, K. T. et al., 1997. Biological screening of 100 plant extracts for cosmetic use (I): inhibitory activities of tyrosinase and DOPA auto-oxidation. International Journal of Cosmetic Science. 19, 291-298. 20.Lin, C.-G., Kao, Y.-T., Liu, W.-T., Huang, H.-H., Chen, K.-C. and Lin, H.-C. 1996. Cytotoxic effects of Bacillus anthracis lethal toxin on macrophage-like cell line. Current Microbiology 33, 224-227. 21.Luckewicz, W. 1990. Determination of ascorbly dipalmitate in cosmetic whitening powders by differential scanning calorimetry. J. Soc. Cosmet. Chem. 41. 359-367. 22.Maeda K. et al. 1991. In vitro effectiveness of several whitening cosmetic components in human melanocytes. J. Soc. Cosm. Chem. 42, 361-368. 23.Masuda, M. et al. 1996. Skin lighteners. Cosmet. Toil. 111, 65-75. 24.Melo, P. S., Duran, N., and Haun, M. Cytotoxicity of prodigisin and benznidazole on V79 cells. 2000. Toxicology letters 116, 237-242. 25.Merot, F., Seniuta, R., Benita, G. and Masson, Ph. 1992. Method for quantifying cutaneous pigmentation in animals and preliminary study in humans. International Journal of Cosmetic Science. 14, 173-182. 26.Motoyoshi, K., Ota, Y., Takuma, Y. and Takenouchi, M. 1998. Wrinkles from UVA exposure. 113, 51-56. 27.Phillips, B. J. 1996. Development of cell culture techniques for assessment of the toxicity of plant products. Toxicology in vitro 10, 69-76. 28.Schallreuter, K. U. et al. 1994. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263. 1444-1446. 29.Shin, N. H. et al. 1998. Oxyresveratrol as the potent inhibitor on - 10 -

dopa oxidase activity of mushroom tyrosinase. Biochememical And Biophysical Research Communications. 243, 801-803. 30.Shirota, S. et al. 1994. Tyrosinase inhibitors from crude drugs. Biol. Pharm. Bull. 17, 266-269. 31.Smith, J. 1996. State of the industry: the Asia-Pacific cosmetics and toiletries sector, 1995. DCI. 24-34. 32.Stern, M. Klausner, M., Alvarado, R., Renskers, K., and Dickens, M. 1998. Evaluation of the EpiOcular tissue model as an alternative to the Draize eye irritation test. Toxicology in vitro 12, 455-461. - 11 -